TriFlex

June 2014: After this lawsuit was transferred to another court in January 2014, a federal judge dismissed the lawsuit concluding that the named-plaintiffs did not establish that the advertisements were false or deceptive. The judge found that the plaintiffs (who did not have arthritis) referred to studies of the effectiveness of glucosamine in people with arthritis and failed to establish that these studies also validly measure the effectiveness of glucosamine in people without arthritis. (In Re: GNC Corp. TriFlex Products Marketing and Sales Practices Litigation, Case No. 14-cv-00033, D. MD.).

December 2013: a class-action lawsuit was filed against GNC for allegedly falsely advertising its TriFlex products containing glucosamine and chondroitin. Specifically, the plaintiffs claim the company promises its TriFlex products will help promote mobility and flexibility, improve joint comfort, and cushion joints without scientific evidence to support such claims. (Brown et al v. GNC Corp., Case No. 13-cv-5890, N. D. CA.).

For more information about other class-action lawsuits regarding glucosamine and TINA’s coverage of the topic, click here.

For more information about other class-action lawsuits filed against GNC and TINA’s coverage of the company, click here.